408 related articles for article (PubMed ID: 28698390)
21. Effect of neuromuscular taping on musculoskeletal disorders secondary to the use of aromatase inhibitors in breast cancer survivors: a pragmatic randomised clinical trial.
Conejo I; Pajares B; Alba E; Cuesta-Vargas AI
BMC Complement Altern Med; 2018 Jun; 18(1):180. PubMed ID: 29890985
[TBL] [Abstract][Full Text] [Related]
22. Yoga versus massage in the treatment of aromatase inhibitor-associated knee joint pain in breast cancer survivors: a randomized controlled trial.
Tsai CL; Liu LC; Liao CY; Liao WL; Liu YH; Hsieh CL
Sci Rep; 2021 Jul; 11(1):14843. PubMed ID: 34290337
[TBL] [Abstract][Full Text] [Related]
23. Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study.
Arem H; Sorkin M; Cartmel B; Fiellin M; Capozza S; Harrigan M; Ercolano E; Zhou Y; Sanft T; Gross C; Schmitz K; Neogi T; Hershman D; Ligibel J; Irwin ML
J Cancer Surviv; 2016 Aug; 10(4):654-62. PubMed ID: 26782031
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic options for aromatase inhibitor-associated arthralgia in breast cancer survivors: A systematic review of systematic reviews, evidence mapping, and network meta-analysis.
Kim TH; Kang JW; Lee TH
Maturitas; 2018 Dec; 118():29-37. PubMed ID: 30415752
[TBL] [Abstract][Full Text] [Related]
25. Interventions for the Treatment of Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Yang GS; Kim HJ; Griffith KA; Zhu S; Dorsey SG; Renn CL
Cancer Nurs; 2017; 40(4):E26-E41. PubMed ID: 27333128
[TBL] [Abstract][Full Text] [Related]
26. Joint pain and falls among women with breast cancer on aromatase inhibitors.
Basal C; Vertosick E; Gillis TA; Li Q; Bao T; Vickers A; Mao JJ
Support Care Cancer; 2019 Jun; 27(6):2195-2202. PubMed ID: 30306326
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Exercise on the Alleviation of Side Effects Induced by Aromatase Inhibitors in Postmenopausal Breast Cancer Patients.
Raptopoulos Z; Constantinou C
Curr Oncol Rep; 2020 Aug; 22(11):110. PubMed ID: 32803384
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial.
Hershman DL; Unger JM; Greenlee H; Capodice J; Lew DL; Darke A; Minasian LM; Fisch MJ; Henry NL; Crew KD
JAMA Netw Open; 2022 Nov; 5(11):e2241720. PubMed ID: 36367721
[TBL] [Abstract][Full Text] [Related]
29. A randomised trial of electro-acupuncture for arthralgia related to aromatase inhibitor use.
Mao JJ; Xie SX; Farrar JT; Stricker CT; Bowman MA; Bruner D; DeMichele A
Eur J Cancer; 2014 Jan; 50(2):267-76. PubMed ID: 24210070
[TBL] [Abstract][Full Text] [Related]
30. Comparing exercise responses to aerobic plus resistance training between postmenopausal breast cancer survivors undergoing aromatase inhibitor therapy and healthy women.
de Paulo TRS; Winters-Stone KM; Viezel J; Rossi FE; Aro BL; Trindade ACAC; Codogno JS; Freitas Junior IF
Disabil Rehabil; 2019 Sep; 41(18):2175-2182. PubMed ID: 29644889
[No Abstract] [Full Text] [Related]
31. Identification of tools to measure changes in musculoskeletal symptoms and physical functioning in women with breast cancer receiving aromatase inhibitors.
Swenson KK; Nissen MJ; Henly SJ; Maybon L; Pupkes J; Zwicky K; Tsai ML; Shapiro AC
Oncol Nurs Forum; 2013 Nov; 40(6):549-57. PubMed ID: 24161633
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness, safety, and economic evaluation of adjuvant moxibustion therapy for aromatase inhibitor-induced arthralgia of postmenopausal breast cancer stage I to III patients: Study protocol for a prospective, randomized, assessor-blind, usual-care controlled, parallel-group, pilot clinical trial.
Shin S; Jang BH; Park SH; Lee JW; Chae MS; Kim N; Suh HS; Han S; Min SY; Baek SK; Lim YJ; Hwang DS
Medicine (Baltimore); 2019 Sep; 98(38):e17260. PubMed ID: 31568000
[TBL] [Abstract][Full Text] [Related]
33. Treatment with Ruta graveolens 5CH and Rhus toxicodendron 9CH may reduce joint pain and stiffness linked to aromatase inhibitors in women with early breast cancer: results of a pilot observational study.
Karp JC; Sanchez C; Guilbert P; Mina W; Demonceaux A; Curé H
Homeopathy; 2016 Nov; 105(4):299-308. PubMed ID: 27914569
[TBL] [Abstract][Full Text] [Related]
34. Arthralgia during aromatase inhibitor treatment in early breast cancer patients: prevalence, impact, and recognition by healthcare providers.
Boonstra A; van Zadelhoff J; Timmer-Bonte A; Ottevanger PB; Beurskens CH; van Laarhoven HW
Cancer Nurs; 2013; 36(1):52-9. PubMed ID: 22495502
[TBL] [Abstract][Full Text] [Related]
35. Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).
Shen S; Unger JM; Crew KD; Till C; Greenlee H; Gralow J; Dakhil SR; Minasian LM; Wade JL; Fisch MJ; Henry NL; Hershman DL
Breast Cancer Res Treat; 2018 Dec; 172(3):603-610. PubMed ID: 30159789
[TBL] [Abstract][Full Text] [Related]
36. Aromatase inhibitor-associated arthralgia syndrome.
Burstein HJ
Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
[TBL] [Abstract][Full Text] [Related]
37. [Aromatase inhibitors and arthralgia].
Nagykálnai T; Landherr L; Mészáros E
Magy Onkol; 2011 Mar; 55(1):32-9. PubMed ID: 21617789
[TBL] [Abstract][Full Text] [Related]
38. Aromatase inhibitor-induced arthralgia: clinical experience and treatment recommendations.
Coleman RE; Bolten WW; Lansdown M; Dale S; Jackisch C; Merkel D; Maass N; Hadji P
Cancer Treat Rev; 2008 May; 34(3):275-82. PubMed ID: 18082328
[TBL] [Abstract][Full Text] [Related]
39. Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer.
Greenlee H; Crew KD; Shao T; Kranwinkel G; Kalinsky K; Maurer M; Brafman L; Insel B; Tsai WY; Hershman DL
Support Care Cancer; 2013 Apr; 21(4):1077-87. PubMed ID: 23111941
[TBL] [Abstract][Full Text] [Related]
40. Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.
Castel LD; Hartmann KE; Mayer IA; Saville BR; Alvarez J; Boomershine CS; Abramson VG; Chakravarthy AB; Friedman DL; Cella DF
Cancer; 2013 Jul; 119(13):2375-82. PubMed ID: 23575918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
